WILLIAM M. O'BRIEN, M.D.
This content is PDF only. Please click on the PDF icon to access.
The studies of Isreal Jaffe early in the 1960s clearly indicated that D-penicillamine was highly effective in treating severe rheumatoid arthritis, particularly rheumatoid arthritis with visceral involvement. His initial observations were confirmed by a carefully controlled English multicenter trial (1). Efficacy of the drug at doses up to 1500 mg/d in treating severe rheumatoid arthritis is not in doubt. In rheumatoid arthritis penicillamine depolymerizes rheumatoid factor. This depolymerization is evidenced during therapy in the falling titer of rheumatoid factor, disappearance of rheumatoid nodules, and improvement in the manifestations of the arthritis. In the English trial (1) the number of the
O'BRIEN WM. Toxicity of D-Penicillamine in Rheumatoid Arthritis. Ann Intern Med. 1980;92:120–122. doi: 10.7326/0003-4819-92-1-120
Download citation file:
Published: Ann Intern Med. 1980;92(1):120-122.
Emergency Medicine, Rheumatoid Arthritis, Rheumatology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use